Genprex, Inc. (GNPX) stock
GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.67−0.23 (-12.08%)
Close on Nov 17, 2026Market cap $1.37MP/E –Yield –
Genprex total assets
Total assets on the balance sheet at the end of each period.
Genprex's total assets was $17.14M at Jun 30, 2026. For fiscal 2025 it was $10.16M, up 146.3% from the year before. The highest annual figure on record is $42.86M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.16M | +146.3% |
| FY2024 | Dec 31, 2024 | $4.12M | -61.3% |
| FY2023 | Dec 31, 2023 | $10.67M | -57.5% |
| FY2022 | Dec 31, 2022 | $25.09M | -41.5% |
| FY2021 | Dec 31, 2021 | $42.86M | +36.6% |
| FY2020 | Dec 31, 2020 | $31.37M | +787.5% |
| FY2019 | Dec 31, 2019 | $3.53M | -61.9% |
| FY2018 | Dec 31, 2018 | $9.27M | +635.9% |
| FY2017 | Dec 31, 2017 | $1.26M | -34.1% |
| FY2016 | Dec 31, 2016 | $1.91M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $17.14M | +347.7% |
| Q1 FY2026 | Mar 31, 2026 | $20.31M | +237.9% |
| Q4 FY2025 | Dec 31, 2025 | $10.16M | +146.3% |
| Q3 FY2025 | Sep 30, 2025 | $3.56M | -8.8% |
| Q2 FY2025 | Jun 30, 2025 | $3.83M | -42.0% |
| Q1 FY2025 | Mar 31, 2025 | $6.01M | -52.2% |
| Q4 FY2024 | Dec 31, 2024 | $4.12M | -61.3% |
| Q3 FY2024 | Sep 30, 2024 | $3.91M | -76.5% |
| Q2 FY2024 | Jun 30, 2024 | $6.60M | -58.5% |
| Q1 FY2024 | Mar 31, 2024 | $12.56M | -46.1% |
| Q4 FY2023 | Dec 31, 2023 | $10.67M | -57.5% |
| Q3 FY2023 | Sep 30, 2023 | $16.64M | -44.4% |
| Q2 FY2023 | Jun 30, 2023 | $15.91M | -54.0% |
| Q1 FY2023 | Mar 31, 2023 | $23.32M | -40.8% |
| Q4 FY2022 | Dec 31, 2022 | $25.09M | -41.5% |
| Q3 FY2022 | Sep 30, 2022 | $29.95M | -35.4% |
| Q2 FY2022 | Jun 30, 2022 | $34.57M | -29.1% |
| Q1 FY2022 | Mar 31, 2022 | $39.41M | -22.8% |
| Q4 FY2021 | Dec 31, 2021 | $42.86M | +36.6% |
| Q3 FY2021 | Sep 30, 2021 | $46.33M | +98.4% |
| Q2 FY2021 | Jun 30, 2021 | $48.73M | +96.9% |
| Q1 FY2021 | Mar 31, 2021 | $51.04M | +107.1% |
| Q4 FY2020 | Dec 31, 2020 | $31.37M | +787.5% |
| Q3 FY2020 | Sep 30, 2020 | $23.35M | +474.0% |
| Q2 FY2020 | Jun 30, 2020 | $24.75M | +295.1% |
| Q1 FY2020 | Mar 31, 2020 | $24.64M | +229.6% |
| Q4 FY2019 | Dec 31, 2019 | $3.53M | -61.9% |
| Q3 FY2019 | Sep 30, 2019 | $4.07M | -63.2% |
| Q2 FY2019 | Jun 30, 2019 | $6.26M | -51.4% |
| Q1 FY2019 | Mar 31, 2019 | $7.48M | +439.3% |
| Q4 FY2018 | Dec 31, 2018 | $9.27M | +635.9% |
| Q3 FY2018 | Sep 30, 2018 | $11.05M | +772.2% |
| Q2 FY2018 | Jun 30, 2018 | $12.89M | +574.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.39M | – |
| Q4 FY2017 | Dec 31, 2017 | $1.26M | – |
| Q3 FY2017 | Sep 30, 2017 | $1.27M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.91M | – |
See a number that looks wrong?